Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Share consolidation
View:
Post by Greenviolino on Mar 29, 2023 10:29am

Share consolidation

Clock is ticking. One more quarter to go before forced share consolidation. Expect 3:1 or 4:1 ratio. Since there shouldn't be any extraordinary news in the next 3-6 months, better to wait after share consolidation to buy again. Could get evem cheaper.
Comment by Trogarzon on Mar 29, 2023 10:53am
It will chop in half again if they do that.  Still they will do it because the board will tell then that it's the good thing to do.  They won't care much because they will vote themselves a new batch next year and on and on.  For the long term shareholder ift wil be death by dilution.  I hope not... I pray not.
Comment by Wino115 on Mar 29, 2023 11:44am
Well, in a few weeks we will hear on 1st quarter sales which they've already said were on target. Half the jump is price related so it only takes converting a percentage of both therapies patients to retain the program and then have some net adds - that seems to be what has been happening over the last 2 years. That will start the process of rebuilding a thesis around sales and cost ...more  
Comment by stephanedodier on Mar 29, 2023 12:49pm
THTX might trade under THERF again ? https://www.yourdictionary.com/therf
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities